FDA label
What is Fetzima used for?
Fetzima contains levomilnacipran. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “FETZIMA® is indicated for the treatment of major depressive disorder (MDD) in adults.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Fetzima?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Fetzima, capsule, extended release
Indications and Usage, quoted from the label by Allergan, Inc. (NDA204168). Cross-references to other label sections are left out.
FETZIMA® is indicated for the treatment of major depressive disorder (MDD) in adults.
Limitation of Use: FETZIMA is not approved for the management of fibromyalgia. The efficacy and safety of FETZIMA for the management of fibromyalgia have not been established.
Source: DailyMed label, set id f371258d-91b3-4b6a-ac99-434a1964c3af, version 33, effective April 30, 2024. NDC 0456-2212, one of 4 listings for this product.
Questions
What is Fetzima used for?
The FDA label says: “FETZIMA® is indicated for the treatment of major depressive disorder (MDD) in adults.”
What drug class is Fetzima?
FDA lists levomilnacipran in the Serotonin and Norepinephrine Reuptake Inhibitor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.